Change in Bleeding Volume in Arthroplasty by Type of Hemostatic Agent

Dose comparison of flowable gelatin hemostatic matrix for bleeding loss in primary arthroplasty - Dose comparison of flowable gelatin hemostatic matrix for bleeding loss in primary arthroplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054871

Enrollment

200

Registered

2024-08-01

Start date

2024-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Use of &quot

hemostatic agents,&quot

which are believed to stop bleeding from bone marrow and soft tissue in arthroplasty No use of &quot

which are believed to stop bleeding from bone marrow and soft tissue in arthroplasty

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing Arthroplasty as usual

Exclusion criteria

Exclusion criteria: patients who rejected to participate this study

Design outcomes

Primary

Measure	Time frame
Perioperative changes in blood loss during arthroplasty	—

Countries

Japan

Contacts

Public ContactShogo Matsuda

University of Oita, Oita, Japan Dept. of Orthop. Surg.

s-matsuda@oita-u.ac.jp08039678476

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026